Abstract
Retinal disease accounts significantly for visual impairment and blindness. An important role in the pathophysiology of retinal disease and aging is attributed to lipofuscin, a complex of fluorescent metabolites. Fundus autofluorescence (AF) imaging allows non-invasive mapping of lipofuscin and is a key technology to diagnose and monitor retinal disease. However, currently used short-wavelength (SW) excitation light has several limitations, including glare and discomfort during image acquisition, reduced image quality in case of lens opacities, limited visualization of the central retina, and potential retinal light toxicity. Here, we establish a novel imaging modality which uses red excitation light (R-AF) and overcomes these drawbacks. R-AF images are high-quality, high-contrast fundus images and image interpretation may build on clinical experience due to similar appearance of pathology as on SW-AF images. Additionally, R-AF images may uncover disease features that previously remained undetected. The R-AF signal increases with higher abundance of lipofuscin and does not depend on photopigment bleaching or on the amount of macular pigment. Improved patient comfort, limited effect of cataract on image quality, and lack of safety concerns qualify R-AF for routine clinical monitoring, e.g. for patients with age-related macular degeneration, Stargardt disease, or for quantitative analysis of AF signal intensity.
Similar content being viewed by others
Explore related subjects
Discover the latest articles, news and stories from top researchers in related subjects.Introduction
Fundus autofluorescence (AF) imaging visualizes fluorophores at the posterior pole. It is a standard method for characterizing, diagnosing, and monitoring retinal disease and is an established outcome measure in clinical trials. The currently most widely used fundus AF imaging devices use short-wavelength (SW) excitation light in the blue or green range. The main fluorophore at this wavelength is lipofuscin which accumulates with ageing in the retinal pigment epithelium (RPE)1,2,3,4. Its increased or decreased abundancy is considered to play a role in the pathophysiology of various degenerative retinal diseases5.
SW-AF imaging has several limitations, which include (I) glare and discomfort during image acquisition6,7; (II) reduced image quality and AF signal intensity in the elderly due to cataract5,8; (III) limited visualization of the central retina due to absorption of the blue excitation light by macular pigment3,5,9; and (IV) potential retinal light toxicity, particularly in patients with inherited retinal diseases10,11,12,13,14,15,16.
The limitations of SW-AF do not apply or should be less relevant when longer wavelength (LW) excitation light is used. However, the currently available near-infrared AF (785 nm excitation, NIR-AF) is characterized by poor AF signal intensity with reduced and less reliable image quality17,18,19. LW excitation with wavelengths shorter than 785 nm should have a higher efficiency20,21.
To leverage the potential of LW-AF, we equipped a custom-built confocal scanning laser ophthalmoscope (cSLO) with red excitation lasers (642 nm and 705 nm; R-AF). This study aimed to evaluate the feasibility, performance and potential advantages of this new imaging modality. Moreover, we provide first evidence that R-AF imaging may have added value when assessing patients with cataract and various retinal diseases, including age-related macular degeneration (AMD) and Stargardt disease.
Results
In normal eyes, R-AF images using 642 nm and 705 nm excitation light showed a consistent pattern. The AF intensity increased slightly from the temporal optic disc margin towards the fovea. In the foveal region (approximately central 5°), signal intensity was usually similar to more eccentric areas using 642 nm excitation light, but was slightly increased with 705 nm excitation light, similar to the usual appearance on 785 nm-excited AF images (Fig. 1).
The potential for detailed assessment of the fovea, the central retinal area that enables high-resolution vision, was particularly evident in comparison to images acquired with 486 nm excitation light, where the macular AF is reduced by the absorption of SW-light by macular pigment and melanin. The RPE-derived AF signal intensity with 785 nm excitation light was lower overall when compared with the other 3 modalities, resulting in poorer contrast. In accordance with the absorption spectrum of hemoglobin22, retinal vessels showed a lower AF signal (relative to background autofluorescence) at 486 nm excitation light, compared to 642 nm and 705 nm excitation light (Supplemental Results 1 and 2).
Image acquisition and analysis
To test whether AF signal intensity changes with exposure to the excitation light, as observed due to bleaching of photopigment when using blue excitation light23, eyes were imaged over 30 s, and grey levels were analyzed over time. No relevant change of the R-AF signal was observed at the fovea or at 12°–17° eccentricity (Supplemental Results 3).
Next, we assessed the effect of defocus on measured AF signal intensity. A slight defocus, which may occur in routine imaging, had no marked impact on the AF signal intensity; a deviation from the focal plane of ± 0.42 D (642 nm) and ± 0.30 D (705 nm), respectively, resulted only in a 5% decrease of the AF signal intensity (Supplemental Results 4).
A linear relation between AF signal intensity and laser power was observed when the laser power was reduced stepwise from its maximum (arbitrary set 100) to 25 with no change of the detector settings (Supplemental Results 5). This assessment also allowed us to estimate the required 642 nm and 705 nm laser power that may result in an AF signal comparable to that using 486 nm excitation light with laser power currently used in clinical routine imaging (Supplemental Results 6). With these fixed laser powers for R-AF, grey levels were determined by the detector settings and followed the equation of
Here, GVsignal is the measured grey value, D is the detector setting used for recording of the image, and 88 is an arbitrarily chosen detector setting that usually results in mid-range grey levels when the standard 486 nm AF imaging is performed in a middle-aged adult without retinal disease. This equation provides arbitrary units (AU) of the AF signal intensity and facilitates quantitative analysis with different detector settings (for more details see Supplemental Results 7).
To investigate test–retest repeatability, subjects moved away from the instrument, the focus was randomly changed while the sensitivity and laser power settings remained fixed. This revealed a repeatability of ± 12% (642 nm) and ± 9% (705 nm), respectively. This measure indicates that higher variation between 2 measurements would only occur in 5% of occasions (95% confidence interval). For additional repeatability and quantitative measures see Supplemental Results 8.
Clinical application: glare, cataract, quantification of autofluorescence intensity
To compare perceived glare of different excitation wavelengths, patients and healthy individuals were asked to rate glare during imaging (10 s) using the subjective de Boer scale which describes the magnitude of discomfort using a 9-point response scale24. Discomfort glare depended on excitation light (Kruskal–Wallis test; p < 0.0001). Image acquisition using 486 nm excitation light was rated significantly more uncomfortable (median: 5.0; interquartile range [IQR] 4–6) compared to 642 nm (median: 6; IQR 5–7), 705 nm (median: 7; IQR 6.5–9), and 788 nm (median: 9; IQR 7–9) (Fig. 2).
In patients with cataract, image quality and evaluation of the retinal morphology is considerably reduced on images acquired with 486 nm excitation light. However, the example of a patient imaged before and after cataract surgery shows that cataract has comparatively much lesser impact on the image quality when 642 nm or 705 nm excitation light is used (Fig. 3).
The potential of R-AF for quantitative analysis of lipofuscin-associated AF is demonstrated in a patient with ABCA4-related retinopathy (Stargardt disease). Compared to healthy controls, the patient showed an increased AF intensity using 642 nm excitation light, comparable to measurements using SW-AF. When using 705 nm excitation light, the increase was less pronounced (Supplemental Results 9).
Case studies
In the following, some clinical examples are presented to illustrate the clinical value of R-AF imaging.
The first example (Fig. 4, top row) shows images of a patient with macular drusen due to age-related macular degeneration. While SW-AF shows mild alterations limited to the central retina (approximately 10°), R-AF shows substantial loss of the AF signal in the same area and more eccentric focal changes. The severe macular changes identified on R-AF imaging showed no obvious correlate on the OCT- and color fundus images.
The second case is a patient with Stargardt disease (Fig. 4, middle row). The R-AF images appear as a composite of the SW-AF and NIR-AF images: While the area of RPE atrophy is better defined on SW- and R-AF images, the latter also show adjacent areas of reduced AF, similar to those observed on the NIR-AF image. A detailed analysis of the foveal region is possible on R-AF images, which is limited on the SW-AF image due to the masking by macular pigment.
Such improved assessment of the fovea is also illustrated in a patient with a vitelliform macular lesion (Fig. 4, bottom row). The R-AF image shows a likely round loss of the RPE-derived AF signal and increased autofluorescence associated with subretinal material mainly in the inferior half of the lesion. These features are not readily visible on the SW-AF image.
R-AF images revealed similar findings as observed on SW-AF images in a case of hydroxychloroquine retinopathy (Fig. 5, top row) and for various retinal dystrophies (not shown). Pigmented fundus lesions usually show an increased signal on NIR-AF, but not on SW-AF images. Such pigmented lesions appeared similar to SW-AF when recorded with 642 nm excitation and similar to NIR-AF, but with fainter signal intensity, when 705 nm excitation light was used (Fig. 5, middle and bottom row).
Discussion
Retinal imaging is a key technique to diagnose and monitor retinal disease. Here, we investigate a novel fundus AF technique using red excitation lasers (642 nm and 705 nm) built into a cSLO. We hypothesized that improved macular assessment would be possible with fewer safety concerns, improved patient comfort, and less influence by cataract compared to short-wavelength AF imaging.
Very little was previously known about the in vivo excitation efficiency of red light for fluorophores at the ocular fundus. In cryosections of human donor eyes, excitation with 633 nm light resulted in a higher AF signal from the RPE relative to Bruch’s membrane and subretinal deposits when compared to shorter excitation wavelengths (364 nm, 486 nm, and 568 nm)25. This indicated that lipofuscin distribution could be mapped with red excitation light, but the study methodology did not allow conclusions on whether the signal intensity would be sufficient for in vivo AF imaging. Our study illustrates the clinical applicability of fundus AF imaging using red excitation light. The topographic distribution of the AF signal with 642 nm excitation light is consistent with previous studies that mapped lipofuscin distribution, often with a localized foveal dip (not shown). In contrast, the slightly higher foveal signal with 705 nm excitation may indicate a more relevant contribution of melanin-/melanolipofuscin-derived AF with increasing wavelength of the excitation light, in line with the observation that the NIR-AF (785 nm) signal strongly depends on the presence of melanin.
Fundus AF imaging using short-wavelength excitation light is considered safe26,27. However, the rationale for safety is based on ANSI thresholds for the healthy retina, whereas ophthalmic imaging is typically performed in patients with retinal disease. Thus, published standards do not cover a potentially lower individual threshold for light damage, e.g. through mutation-specific effects, a reduced reserve for recovery, or the contribution of endogenous photosensitizers, particularly in patients with retinal dystrophies19. Light-dependent acceleration of retinal degeneration in susceptible retinas has, for instance, been shown in an animal model with rhodopsin mutation12,13,14,16,28. Replacing blue for red excitation light for fundus AF imaging results in lower energy per photon, and photochemical toxicity does not need to be considered for light with wavelengths > 600 nm. This allows to apply more laser energy and to compensate for potentially lower fluorescence efficiency. Moreover, retinal light damage is thought to be tightly linked to light absorption by rhodopsin, but red light is outside its absorption spectrum and tissue absorption at wavelengths between 600 to 1300 nm is relatively low12,13,14,29. Cones are much less vulnerable to light damage, but even if there is a role for cone opsins, absorption efficiency is low at 642 nm and 705 nm30.
Substitution of potentially harmful short-wavelength light by safer longer wavelength light appears particularly logical for repetitive examinations and for quantitative AF intensity measurements which may be used as a biomarker for lipofuscin accumulation15,16. Besides its diagnostic usefulness, such quantitative R-AF imaging may serve as a safe outcome measure in clinical trials that aim at lowering lipofuscin accumulation. Our study provides first evidence that R-AF may indeed be used to quantify lipofuscin-associated AF intensity, without the requirement of photopigment bleaching.
Retinal imaging using visible light is often associated with considerable discomfort glare31,32. Photophobia increases with decreasing wavelength, and it was therefore expected that R-AF would be better tolerated6,7. However, discomfort glare also depends on the light intensity, and it was unknown if excitation light resulting in a clinically useful AF signal intensity would be more comfortable than short-wavelength excitation light6,7. In this study, we show that R-AF imaging with excitation light intensities resulting in similar AF signal as on conventional SW-AF is indeed associated with improved patient comfort.
Media opacities, in particular nuclear cataracts, have a relevant impact on image quality on SW-AF images, often preventing precise analysis of retinal changes8. Lenses with cataract absorb and scatter the blue excitation light, and their autofluorescence may reduce the contrast of the fundus AF image5. On the contrary, R-AF imaging in patients with cataract resulted in high-quality recordings and hence would be a more favorable imaging modality for patients with cataracts, even though it requires additional studies to investigate the exact impact of cataract types and severity.
Finally, this study provides first evidence of the clinical usefulness of R-AF imaging. The observed AF patterns were remarkably similar to findings on SW-AF imaging and hence, clinicians may build on previous experience for image interpretation. Moreover, we demonstrate that additional information can be embedded in R-AF images. For instance, R-AF in ABCA4-related retinopathy showed the combined information of SW-AF and NIR-AF alterations, hence allowing a more comprehensive analysis by means of only one image (Fig. 4). Of note, NIR-AF images are rarely recorded in clinical routine due to their lower contrast, but clinical information encoded in NIR-AF images of patients with ABCA4-related retinopathy may be functionally relevant and may uncover early pathology33,34,35,36,37. The observation that characteristic flecks in ABCA4-related retinopathy usually show a high signal on SW-AF but not on R-AF supports previous reports suggesting that these flecks do not represent lipofuscin accumulation in the RPE, but are rather composed of different fluorophores that may accumulate in the subretinal space34,37. This also illustrates that various fluorophores at the ocular fundus may only be visualized using specific excitation wavelengths and that such differences may inform on deviating pathophysiological processes. Another example for additional information on R-AF images is the loss of AF signal in a central retinal area of an eye with AMD that shows no correlate on fundus color photography, SW-AF- or OCT-imaging (Fig. 4). Understanding the cause of this appearance as well as the significance with regards to disease stratification and prognostication will require further studies. Furthermore, R-AF allows improved analysis of foveal pathologies because red light is not absorbed by macular pigment. The resulting lack of foveal masking, which limits foveal assessment when blue-excitation light is used, allows a detailed evaluation of macular diseases, including AMD and Stargardt disease9,38,39.
Limitations of R-AF include that red light is outside the excitation spectrum of fluorescein and hence cannot be used for fluorescein angiography. However, if R-AF imaging would be incorporated in future devices as an additional modality, it could be performed between mid- and late-phase fluorescein angiography recordings and hence improve clinic flow. Red light may also be inefficient for exciting indocyanine green, but the feasibility of ICG angiography would require further investigations40. As red light is not absorbed by macular pigment (lutein and zeaxanthin) characteristic lack or redistribution of macular pigment as observed e.g. associated with foveal hypoplasia or in macular telangiectasia type 2 may not be detected41,42. Furthermore, we investigated only a relatively small number of subjects and diseases; hence, general conclusions will require further disease-specific studies.
In conclusion, R-AF allows comprehensive retinal analysis, may provide additional information about retinal disease, and may facilitate retinal imaging with improved patient comfort and fewer safety concerns compared to the currently most widely used AF technologies. Quantitative R-AF imaging may serve as a sensitive and safe outcome measure in clinical trials that aim at lowering lipofuscin accumulation. Thus, R-AF holds great potential for both clinical practice and (clinical) research and appears to be an ideal retinal imaging modality.
Methods
Participants
This prospective, cross-sectional study (NCT03592017, first registered 19/07/2018) was conducted at the Oxford Eye Hospital, Oxford University Hospitals NHS Foundation Trust, and the Nuffield Laboratory of Ophthalmology, Nuffield Department of Clinical Neurosciences, University of Oxford, Oxford, United Kingdom. The study was in adherence to the declaration of Helsinki. Institutional review board approval (Health Research Authority, South Central—Oxford C Research Ethics Committee) and patients' informed consent were obtained.
In total, 80 participants were investigated, including 15 healthy subjects with normal retinal status, good fixation, and clear media and 65 patients with retinal disease.
Safety considerations
Following the recommendations of the American National Standards Institute (ANSI), the retinal light exposure of the R-AF imaging lasers is markedly (≈ 8–12 times) below the accessible emission limit (AEL) of class 1 laser products26,27. As the wavelength of both R-AF lasers is > 600 nm, no photochemical retinal hazard has to be considered; photochemical retinal hazard is a fundamental element in the safety review of SW-AF (see the Supplementary Methods for additional information).
Image acquisition
We used a custom-built confocal scanning laser ophthalmoscope (Heidelberg Engineering, Heidelberg, Germany) equipped with lasers for excitation at 642 nm (barrier filter: 652 nm), 705 nm (barrier filter: 715 nm), and 785 nm (barrier filter: 798 nm). The study focused on investigating the performance of red-light fundus autofluorescence (R-AF) using the 642 nm and 705 nm excitation lasers. For selected clinical aspects, images were compared with NIR- and SW-AF images. The latter were recorded using the 486 nm laser (barrier filter: 496 nm) of a commercial Spectralis HRA + OCT (Heidelberg Engineering) (see Supplemental Methods 1 for additional information).
Before imaging, pupils were dilated by instillation of 0.5% tropicamide and 2.5% phenylephrine. The camera was positioned centered on the fovea of the participant by using the near-infrared reflectance mode and the internal fixation light. After switching to the AF mode, focus and alignment were readjusted to obtain a maximum and uniform signal. The optimal camera position was re-checked, and the participant was asked to blink a few times to provide optimal imaging conditions. A series of 12 successive images were recorded (30° field of view and 1536 × 1536 pixels) and a quality check was performed after the recording of each series. In case of insufficient quality (e.g. due to inhomogeneous illumination, unstable fixation, sectorial opacities such as eyelashes or floaters), images were excluded from further analysis.
Recorded AF images display the spatial distribution of the AF signal intensity for each pixel in an 8-bit grayscale image (range, 0 to 255). Low pixel values (dark) indicate low AF intensities and high pixel values (light) represent high AF intensities5. Unless stated otherwise, no image processing was performed. Histogram stretching (“normalization”) was used to improve contrast in cases where only qualitative assessment was performed.
Image analysis
An in-house image processing pipeline, written in Python and based on the open-source SciPy library, was used for image analysis. First, the foveal center and the temporal neuroretinal edge of the optic disc were manually labeled and checked by an additional rater. The distance between the edge of the disc and the foveal center (FD) was then used to align and scale the measurement areas which was adapted from previous reports4,23,43,44,45,46. Measurements were performed in four concentric rings around the fovea and a circular foveal segment; the three outer rings were divided into eight segments and the innermost ring was divided into four segments (Supplemental Methods 2). The image processing pipeline accounted for the presence of vessels by fitting the sum of two Gaussians to the histogram of every segment as performed in previous studies4,23,43,44,45. Here, we assume that the smaller Gaussian accounts for lower grey values of the vessels and the larger Gaussian for the grey values of the fundus background. Thus, the minimum grey value of the fundus is then set at the 5%-quantile of the larger Gaussian. Segments extending beyond 15° from the center of the image were excluded. The grey values were corrected by subtracting the “Grey value offset” which is the signal measured in the dark mode (detector on, laser modulated off). The respective values of each image are provided by the Heidelberg Spectralis software46.
Statistical analyses
Statistical Analyses were performed using SciPy, Microsoft Excel (Microsoft, Redmond, WA, USA), and graphing software (GraphPad Prism, La Jolla, CA, USA). To measure test–retest repeatability and agreement between two measures obtained from different image acquisition modes, the method of Bland and Altmann was used47. The coefficient of repeatability (or agreement) between two measures qAF1 and qAF2, expressed in percent, is repeatability = ± 1.96 ⋅ σqAF ⋅ 100, where σqAF is the standard deviation of ΔqAF = 2(qAF1 − qAF2)/(qAF1 + qAF2) across all considered image pairs. The here presented repeatability coefficient can be interpreted as a 95% confidence interval for testing under the same conditions, while the analogously defined agreement coefficient can be interpreted as a 95% confidence interval for switching between different image acquisition modes.
Data availability
The datasets generated and analyzed during the current study are not publicly available due to data protection regulations but are available from the corresponding author on reasonable request.
References
Wing, G. L., Blanchard, G. C. & Weiter, J. J. The topography and age relationship of lipofuscin concentration in the retinal pigment epithelium. Investig. Ophthalmol. Vis. Sci. 17, 601–607 (1978).
Weiter, J. J., Delori, F. C., Wing, G. L. & Fitch, K. A. Retinal pigment epithelial lipofuscin and melanin and choroidal melanin in human eyes. Investig. Ophthalmol. Vis. Sci. 27, 145–152 (1986).
Delori, F. C. et al. In vivo fluorescence of the ocular fundus exhibits retinal pigment epithelium lipofuscin characteristics. Investig. Ophthalmol. Vis. Sci. 36, 718–729 (1995).
Greenberg, J. P. et al. Quantitative fundus autofluorescence in healthy eyes. Investig. Ophthalmol. Vis. Sci. 54, 5684–5693. https://doi.org/10.1167/iovs.13-12445 (2013).
Schmitz-Valckenberg, S. et al. Fundus autofluorescence imaging. Prog. Retin. Eye Res. 81, 100893. https://doi.org/10.1016/j.preteyeres.2020.100893 (2020).
Stringham, J. M., Fuld, K. & Wenzel, A. J. Action spectrum for photophobia. J. Opt. Soc. Am. A Opt. Image Sci. Vis. 20, 1852–1858. https://doi.org/10.1364/josaa.20.001852 (2003).
Bullough, J. D. Spectral sensitivity for extrafoveal discomfort glare. J. Mod. Opt. 56, 1518–1522. https://doi.org/10.1080/09500340903045710 (2009).
Delori, F. C. & Burns, S. A. Fundus reflectance and the measurement of crystalline lens density. J. Opt. Soc. Am. A Opt. Image Sci. Vis. 13, 215–226 (1996).
Davies, N. P. & Morland, A. B. Macular pigments: Their characteristics and putative role. Prog. Retin. Eye Res. 23, 533–559. https://doi.org/10.1016/j.preteyeres.2004.05.004 (2004).
Morgan, J. I. et al. Light-induced retinal changes observed with high-resolution autofluorescence imaging of the retinal pigment epithelium. Investig. Ophthalmol. Vis. Sci. 49, 3715–3729. https://doi.org/10.1167/iovs.07-1430 (2008).
Hunter, J. J. et al. The susceptibility of the retina to photochemical damage from visible light. Prog. Retin. Eye Res. 31, 28–42. https://doi.org/10.1016/j.preteyeres.2011.11.001 (2012).
Wang, M., Lam, T. T., Tso, M. O. & Naash, M. I. Expression of a mutant opsin gene increases the susceptibility of the retina to light damage. Vis. Neurosci. 14, 55–62. https://doi.org/10.1017/s0952523800008750 (1997).
Budzynski, E. et al. Mutations of the opsin gene (Y102H and I307N) lead to light-induced degeneration of photoreceptors and constitutive activation of phototransduction in mice. J. Biol. Chem. 285, 14521–14533. https://doi.org/10.1074/jbc.M110.112409 (2010).
Cideciyan, A. V. et al. In vivo dynamics of retinal injury and repair in the rhodopsin mutant dog model of human retinitis pigmentosa. Proc. Natl. Acad. Sci. U.S.A. 102, 5233–5238. https://doi.org/10.1073/pnas.0408892102 (2005).
Paskowitz, D. M., LaVail, M. M. & Duncan, J. L. Light and inherited retinal degeneration. Br. J. Ophthalmol. 90, 1060–1066. https://doi.org/10.1136/bjo.2006.097436 (2006).
Teussink, M. M. et al. Lipofuscin-associated photo-oxidative stress during fundus autofluorescence imaging. PLoS One 12, e0172635. https://doi.org/10.1371/journal.pone.0172635 (2017).
Piccolino, F. C., Borgia, L., Zinicola, E., Iester, M. & Torrielli, S. Pre-injection fluorescence in indocyanine green angiography. Ophthalmology 103, 1837–1845. https://doi.org/10.1016/s0161-6420(96)30418-1 (1996).
Keilhauer, C. N. & Delori, F. C. Near-infrared autofluorescence imaging of the fundus: Visualization of ocular melanin. Investig. Ophthalmol. Vis. Sci. 47, 3556–3564. https://doi.org/10.1167/iovs.06-0122 (2006).
Cideciyan, A. V. et al. Reduced-illuminance autofluorescence imaging in ABCA4-associated retinal degenerations. J. Opt. Soc. Am. A Opt. Image Sci. Vis. 24, 1457–1467 (2007).
Huang, Z. et al. Raman spectroscopy of in vivo cutaneous melanin. J. Biomed. Opt. 9, 1198–1205. https://doi.org/10.1117/1.1805553 (2004).
Vienola, K. V. et al. Near infrared autofluorescence imaging of retinal pigmented epithelial cells using 663 nm excitation. Eye (Lond) https://doi.org/10.1038/s41433-021-01754-0 (2021).
Koenig, K. & Schneckenburger, H. Laser-induced autofluorescence for medical diagnosis. J. Fluoresc. 4, 17–40. https://doi.org/10.1007/BF01876650 (1994).
Delori, F. et al. Quantitative measurements of autofluorescence with the scanning laser ophthalmoscope. Investig. Ophthalmol. Vis. Sci. 52, 9379–9390. https://doi.org/10.1167/iovs.11-8319 (2011).
Illuminating Engineering Society London. Evaluation of Discomfort Glare: The I.E.S. Glare Index System for Artificial Lighting Installations (Illuminating Engineering Society, 1967).
Marmorstein, A. D., Marmorstein, L. Y., Sakaguchi, H. & Hollyfield, J. G. Spectral profiling of autofluorescence associated with lipofuscin, Bruch’s Membrane, and sub-RPE deposits in normal and AMD eyes. Investig. Ophthalmol. Vis. Sci. 43, 2435–2441 (2002).
ANSI. American National Standard for Safe Use of Lasers (ANSI Z136.1) (The Laser Institute of America, 2014).
Delori, F. C., Webb, R. H., Sliney, D. H., American National Standards Institute. Maximum permissible exposures for ocular safety (ANSI 2000), with emphasis on ophthalmic devices. J. Opt. Soc. Am. A Opt. Image Sci. Vis. 24, 1250–1265. https://doi.org/10.1364/josaa.24.001250 (2007).
Orlans, H. O. et al. Filtration of short-wavelength light provides therapeutic benefit in retinitis pigmentosa caused by a common rhodopsin mutation. Investig. Ophthalmol. Vis. Sci. 60, 2733–2742. https://doi.org/10.1167/iovs.19-26964 (2019).
Tsai, C. L., Chen, J. C. & Wang, W. J. Near-infrared absorption property of biological soft tissue constituents. J. Med. Biol. Eng. 21, 7–14 (2001).
Imamoto, Y. & Shichida, Y. Cone visual pigments. Biochim. Biophys. Acta 1837, 664–673. https://doi.org/10.1016/j.bbabio.2013.08.009 (2014).
Mainster, M. A. & Turner, P. L. Glare’s causes, consequences, and clinical challenges after a century of ophthalmic study. Am. J. Ophthalmol. 153, 587–593. https://doi.org/10.1016/j.ajo.2012.01.008 (2012).
Otsuka, Y. et al. Wavelength of light and photophobia in inherited retinal dystrophy. Sci. Rep. 10, 14798. https://doi.org/10.1038/s41598-020-71707-2 (2020).
Kellner, S. et al. Lipofuscin- and melanin-related fundus autofluorescence in patients with ABCA4-associated retinal dystrophies. Am. J. Ophthalmol. 147, 895–902, 902 e891. https://doi.org/10.1016/j.ajo.2008.12.023 (2009).
Sparrow, J. R. et al. Flecks in recessive Stargardt disease: Short-wavelength autofluorescence, near-infrared autofluorescence, and optical coherence tomography. Investig. Ophthalmol. Vis. Sci. 56, 5029–5039. https://doi.org/10.1167/iovs.15-16763 (2015).
Duncker, T. et al. Correlations among near-infrared and short-wavelength autofluorescence and spectral-domain optical coherence tomography in recessive Stargardt disease. Investig. Ophthalmol. Vis. Sci. 55, 8134–8143. https://doi.org/10.1167/iovs.14-14848 (2014).
Müller, P. L. et al. Functional relevance and structural correlates of near infrared and short wavelength fundus autofluorescence imaging in ABCA4-related retinopathy. Transl. Vis. Sci. Technol. 8, 46. https://doi.org/10.1167/tvst.8.6.46 (2019).
Paavo, M., Lee, W., Allikmets, R., Tsang, S. & Sparrow, J. R. Photoreceptor cells as a source of fundus autofluorescence in recessive Stargardt disease. J. Neurosci. Res. 97, 98–106. https://doi.org/10.1002/jnr.24252 (2019).
Snodderly, D. M., Brown, P. K., Delori, F. C. & Auran, J. D. The macular pigment. I. Absorbance spectra, localization, and discrimination from other yellow pigments in primate retinas. Investig. Ophthalmol. Vis. Sci. 25, 660–673 (1984).
Whitehead, A. J., Mares, J. A. & Danis, R. P. Macular pigment: A review of current knowledge. Arch. Ophthalmol. 124, 1038–1045. https://doi.org/10.1001/archopht.124.7.1038 (2006).
Alander, J. T. et al. A review of indocyanine green fluorescent imaging in surgery. Int. J. Biomed. Imaging 2012, 940585. https://doi.org/10.1155/2012/940585 (2012).
Charbel Issa, P. et al. Macular telangiectasia type 2. Prog. Retin. Eye Res. 34, 49–77. https://doi.org/10.1016/j.preteyeres.2012.11.002 (2013).
Pauleikhoff, L. et al. Fundus autofluorescence imaging in macular telangiectasia type 2: MacTel Study Report Number 9. Am. J. Ophthalmol. 228, 27–34. https://doi.org/10.1016/j.ajo.2021.03.022 (2021).
Burke, T. R. et al. Quantitative fundus autofluorescence in recessive Stargardt disease. Investig. Ophthalmol. Vis. Sci. 55, 2841–2852. https://doi.org/10.1167/iovs.13-13624 (2014).
Gliem, M. et al. Quantitative fundus autofluorescence in early and intermediate age-related macular degeneration. JAMA Ophthalmol. 134, 817–824. https://doi.org/10.1001/jamaophthalmol.2016.1475 (2016).
Gliem, M. et al. Quantitative fundus autofluorescence and genetic associations in macular, cone, and cone-rod dystrophies. Ophthalmol Retina 4, 737–749. https://doi.org/10.1016/j.oret.2020.02.009 (2020).
Charbel Issa, P. et al. Optimization of in vivo confocal autofluorescence imaging of the ocular fundus in mice and its application to models of human retinal degeneration. Investig. Ophthalmol. Vis. Sci. 53, 1066–1075. https://doi.org/10.1167/iovs.11-8767 (2012).
Bland, J. M. & Altman, D. G. Statistical methods for assessing agreement between two methods of clinical measurement. Lancet 1, 307–310 (1986).
Acknowledgements
This work was supported by the National Institute for Health Research (NIHR) Oxford Biomedical Research Centre (BRC), the Dr. Werner Jackstädt Foundation, Wuppertal, Germany (Grant S0134-10.22 to J.B. and S134-10.118 to L.P.), the Deutsche Forschungsgemeinschaft (DFG), Bonn, Germany (Grant GL920/1-1 to M.G.), and the Bayer Global Ophthalmology Awards Program (J.B.). The funding organizations had no role in the design and conduct of the study; collection, management, analysis, and interpretation of the data; preparation, review, or approval of the manuscript; and decision to submit the manuscript for publication. The views expressed are those of the authors and not necessarily those of the NHS, the NIHR, or the Department of Health. We are grateful for the support from Heidelberg Engineering and in particular for the collaboration with Jörg Fischer PhD, Heidelberg Engineering.
Author information
Authors and Affiliations
Contributions
Conception and design of the work: J.B., M.G., P.C.I. Acquisition, analysis, and interpretation of data: all authors. Drafting of the manuscript: J.B., T.B., P.C.I. Revision of the manuscript: L.P., T.R., M.G. Approval of the final version of the manuscript: all authors. Agreed both to be personally accountable for the author’s own contributions and to ensure that questions related to the accuracy or integrity of any part of the work, even ones in which the author was not personally involved, are appropriately investigated, resolved, and the resolution documented in the literature: all authors.
Corresponding author
Ethics declarations
Competing interests
PCI has received imaging equipment from Heidelberg Engineering. All other authors declare no competing interests.
Additional information
Publisher's note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Supplementary Information
Rights and permissions
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.
About this article
Cite this article
Birtel, J., Bauer, T., Pauleikhoff, L. et al. Fundus autofluorescence imaging using red excitation light. Sci Rep 13, 9916 (2023). https://doi.org/10.1038/s41598-023-36217-x
Received:
Accepted:
Published:
DOI: https://doi.org/10.1038/s41598-023-36217-x
- Springer Nature Limited